Gilteritinib and venetoclax regimen yields encouraging results against FLT3-mutated AML
A new regimen of FMS-related tyrosine kinase 3 (FLT3) inhibitor gilteritinib and venetoclax was tolerable at standard doses and produced high response rates for advanced, FLT3-mutated acute myeloid leukemia (AML) in a multicenter Phase 1 [...]
View more
PSMA PET scan is catching cancer earlier and with greater accuracy than ever before
Accurate imaging is a crucial component of prostate cancer management for a number of reasons, including tumor localization, disease staging and detecting recurrence. Prostate-specific membrane antigen positron emission tomography (PSMA PET) scans offer an imaging […]
View more
Certified pediatric hematology/oncology nurse Sable C. Iglesias, DNP, APRN, CPHON, joins Norton Children’s Cancer Institute
Sable C. Iglesias, DNP, APRN, CPHON, has joined Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, as a certified pediatric hematology/oncology nurse. A Louisville native, Sable graduated from University of Louisville with two […]
View more
Clinical Update: Defeating cancer with multidisciplinary care, discoveries and customized care
Each year, as we look back over our progress and program highlights, we are struck by a singular fact. Time and again, what we are able to achieve is the result of exceptional teamwork. Our [...]
View more
Clinical trials build expertise with new treatments before they’re widely available
At Norton Cancer Institute, we are committed to giving our patients the opportunity to receive state-of-the-art, cutting-edge therapies. This is made possible because of the long-standing support of clinical trials by Norton Healthcare’s leadership and [...]
View more
Advances in early detection of ovarian cancer
Ovarian cancer is personal to me. Two of my mom’s sisters died of the disease. One of the major issues with successfully treating ovarian cancer is how late it is typically diagnosed: stage IIIC. At […]
View more
Gynecologic oncologist Justin W. Gorski, M.D., Ph.D., joins Norton Cancer Institute
Justin W. Gorski, M.D., Ph.D., has joined Norton Cancer Institute, specializing in treating cancers of the female reproductive system, including ovarian, uterine and cervical cancers. Dr. Gorski is a board-certified gynecologic oncologist. He received his […]
View more
Advancing the standard of cancer care and offering patients access to new therapies
Our goal is to offer every patient the option of the latest treatment available for their cancer. To do that, Norton Cancer Institute is participating in approximately 170 clinical trials at any time. These clinical [...]
View more
Addressing emotional health is a vital part of cancer care
Cancer is a disease that impacts each individual differently. There is no one-size-fits-all approach to compassion and care. Just as we deliver individualized medicine, we deliver individualized care to ensure we meet the needs of […]
View more
Freezing giant cell tumor of bone: Case study
The patient A 25-year-old woman presented with recurrent left second metacarpal giant cell tumor of bone. She previously was treated with extensive curettage, bone graft substitute placement and Kirschner wire fixation. Giant cell tumor of [...]
View more
Amplified cardiopulmonary recordings as a music therapy intervention
Bereaved family members of adult oncology patients appear to have moderate acceptance and use of amplified cardiopulmonary recordings (ACPR) when created in the context of ongoing music therapy treatment, according to a recently published study. […]
View more
Mia Jusufbegovic, M.D., joins Norton Cancer Institute
Mia Jusufbegovic, M.D., has joined Norton Cancer Institute as its first head and neck oncology and microvascular reconstructive surgeon treating complex ear, nose and throat oncology cases. Dr. Jusufbegovic earned her medical degree from the […]
View more